Hunter-Fleming Ltd Report issue

For profit Phase 2
Founded: Bristol United Kingdom (1999)
Status: Acquired by Newron Pharmacueticals (2008)

Organization Overview

First Clinical Trial
2006
NCT00357357
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree